Cleared Traditional

K821571 - TP440 ORTHOPROBE

K821571 is an FDA 510(k) clearance for TP440 ORTHOPROBE, manufactured by Grove Video Corp.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 55-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1982
Decision
55d
Days
Class 2
Risk

K821571 is an FDA 510(k) clearance for the TP440 ORTHOPROBE. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Grove Video Corp. (Mchenry, US). The FDA issued a Cleared decision on July 21, 1982 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K821571

510(k) Number K821571 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 1982
Decision Date July 21, 1982
Days to Decision 55 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 149d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K821571.
THE EMD TENZ PAIN CONTROL SYSTEM
K822841 · Electro Medical Development · Nov 1982
PRO MED 100
K822854 · Rebco Trading Co. · Oct 1982
NEUROMEDICS ORIONS #660-01
K822600 · Intermedics, Inc. · Sep 1982
OMNI TENS
K821523 · Omni Intl., Inc. · Jun 1982
TRANS-Q
K821363 · Chesapeake Medical Assoc. · May 1982
BIGSTON TRANSCUTANEOUS NERVE STIMULAT
K820326 · Canadian Medical Products · Apr 1982